The three types of cataracts are nuclear sclerotic, cortical, and posterior subcapsular, classified by which layer of the lens clouding begins in. Nuclear cataract forms in the dense center and slowly yellows the lens over years. Cortical cataract starts at the outer edge and sends spoke-like opacities inward. Posterior subcapsular cataract sits at the back surface and can blur vision within months. Each type has a distinct appearance, speed, and set of visual symptoms, which is why the type matters for timing surgery.

What a Cataract Actually Is at the Protein Level

The lens is a transparent disc of tightly packed protein fibers, and it has no blood supply. It stays clear because crystallin proteins are arranged in a precise short-range order that lets about 98 percent of visible light pass straight through. A cataract is that order breaking down.

Two mechanisms drive the breakdown. First, proteins unfold and clump into high-molecular-weight aggregates. These aggregates scatter light instead of transmitting it, and the scatter is what you perceive as haze or glare. Second, the lens accumulates osmotic stress as fiber cells lose their pumps, drawing in water and swelling.

In plain terms: a cataract is not a growth or a film on the eye. It is the lens's own protein architecture degrading from the inside, which is why no drop or diet removes it.

The location of that degradation defines the three cataract types. Nuclear changes happen in the oldest fibers at the center. Cortical changes happen where newer fibers meet the capsule. Posterior subcapsular changes happen at the back pole, where fiber migration is most active.

The Three Types Side by Side

The comparison below reconciles how each type looks, progresses, and behaves. Note the numbers: onset ages and progression rates differ by type, and those differences change when surgery is reasonable.

Feature Nuclear sclerotic Cortical Posterior subcapsular
Location in lens Central nucleus Outer cortex, spoke pattern Back surface, just inside capsule
Typical onset age 60s to 70s 50s to 70s Any age, often 30s to 50s
Rate of progression Slow, 5 to 15 years Moderate, 2 to 10 years Fast, 3 to 18 months
Early visual symptom Blur, dulled colors, glare at night Glare and halos from light scatter Reading and near-vision blur, glare in bright light
Signature phenomenon Myopic shift ("second sight") Wedge-shaped shadows at lens edge Disproportionate loss with small pupils
Diabetic association Moderate Strong Strong
Steroid association Weak Moderate Strongest of the three
Common in younger patients Rare Sometimes Yes, most common type under 50

The rate ranges overlap because cataract speed depends on comorbidity, sunlight dose, and genetics, not type alone. Nuclear cataract is the most common type overall, accounting for roughly 60 to 70 percent of age-related cases in population studies.

Nuclear Sclerotic Cataract: The Slow Yellowing

Nuclear cataract begins in the lens nucleus, the embryonic core formed before birth. Those central fibers are never replaced, so damage there accumulates over a lifetime. The nucleus compresses and hardens, a process called nuclear sclerosis, and its color shifts from clear to yellow to amber to brown.

That color shift matters optically. Yellow pigment absorbs short blue wavelengths, so contrast and color discrimination decline before acuity does. Patients often report that white looks cream and blue looks gray. The refractive index of the nucleus also rises, which bends light more strongly.

This refractive change produces the counterintuitive "second sight" phenomenon. A hyperopic patient in their 60s may suddenly read without glasses. It looks like improvement but signals progression.

One graded scale, the Lens Opacities Classification System III, scores nuclear color, nuclear opacity, cortical opacity, and posterior subcapsular opacity separately on standardized photographic scales. A nuclear score of 4 or higher usually correlates with visually significant impairment.

Nuclear cataract progresses slowly, often over 5 to 15 years. Because it is slow, patients frequently adapt and delay surgery far longer than necessary. A professional caveat: dense brown nuclear cataract, called brunescent cataract, is technically harder to remove because the nucleus is rigid. Very advanced nuclear cataract requires more ultrasound energy during phacoemulsification, raising the risk of corneal endothelial stress.

Cortical Cataract: The Spokes From the Edge

Cortical cataract starts in the lens cortex, the younger fiber layers just under the capsule. The earliest sign is a fluid-filled cleft between fiber layers, visible as a spoke or wedge radiating inward from the lens equator. Ophthalmologists call these cortical spokes, and they appear as dark radial bands against the red reflex.

The mechanism is osmotic. Cortical fiber cells lose membrane integrity, calcium influx rises, and water enters the spaces between fibers. Swelling separates fiber lamellae and creates the clefts. As the clefts grow and merge, light scatters at their edges.

Cortical cataract creates a specific glare pattern. Because the opacities sit at the lens periphery, they scatter light rays that would normally pass through the pupillary margin. At night, with a dilated pupil, more of the cortex is exposed and glare and halos worsen. In bright light, a constricted pupil can mask the cataract, so acuity tested in a dim room may look worse than the patient's daylight experience.

Cortical cataract has the strongest association with diabetes of the three types. Chronic hyperglycemia drives polyol pathway flux, converting glucose to sorbitol inside lens cells, and sorbitol draws water in. This links cortical cataract directly to glycemic control, with risk rising measurably above an HbA1c of roughly 7 percent in longitudinal studies.

Posterior Subcapsular Cataract: The Fast One at the Back

Posterior subcapsular cataract, or PSC, forms at the posterior pole of the lens, just inside the capsule. It appears as a granular, plaque-like opacity directly in the optical center. Because it sits on the visual axis, it interferes with vision out of proportion to its size.

PSC has two features that make it clinically distinctive. First, it progresses faster than the other types, often within 3 to 18 months. Second, it causes dramatic near-vision loss because small pupils and constricted lighting concentrate light through the central opacity.

This produces a paradox worth correcting. A patient may read 20/25 on a standard Snellen chart in dim light yet be unable to read a menu in a bright restaurant. Bright light constricts the pupil, forcing light through the dense central plaque. The professional term is disproportionate glare disability, and it is a classic PSC clue.

PSC is the most steroid-associated cataract type. Prolonged systemic corticosteroid use, inhaled steroids at high doses, and topical ocular steroids all raise PSC risk. The relationship is dose and duration dependent, with meaningful risk emerging after roughly 1 year of systemic prednisone above 5 to 10 mg per day. PSC is also the type most common in younger patients and in people with diabetes, and it appears in up to half of patients with atopic dermatitis who receive long-term steroid therapy.

How Fast Each Type Progresses: A Timeline

The timeline below gives expected milestones. Ranges are broad because individual rate depends on age at onset, UV exposure, smoking, and diabetes control. Cataract is not reversible, so every row trends forward, never back.

Time from onset Nuclear Cortical Posterior subcapsular
0 to 6 months Minimal color shift Faint peripheral spokes Small central plaque, early glare
6 to 12 months Slow yellowing, glare at night Spokes lengthen inward Noticeable near blur, glare in bright light
1 to 2 years Mild blur, contrast loss Wedges reach mid-periphery Marked acuity drop, surgery often discussed
2 to 5 years Moderate yellowing, myopic shift Moderate scatter, night driving difficulty Advanced plaque if untreated
5 to 10 years Dense nucleus, brunescence possible Significant cortical opacity Rarely reaches this stage untreated
10 to 15 years Mature or brunescent cataract Mature cataract Not applicable
Surgery threshold When daily function drops When glare impairs night vision Often earliest of the three

The surgery threshold row reconciles the speed differences: PSC triggers functional impairment years before nuclear cataract typically does, not because it is more severe at the endpoint but because it reaches the visual axis faster.

Variations and Edge Cases That Break the Pattern

Mixed cataract is the rule, not the exception. Most patients over 70 have two or three types simultaneously, and pure single-type cataract is uncommon in older adults. Clinicians grade each component separately.

Congenital and pediatric cataract is a separate category with different urgency. A dense congenital cataract blocking the visual axis must be removed within the first 6 to 8 weeks of life to prevent permanent amblyopia, because the visual cortex is still wiring. This is the one cataract scenario where delay causes irreversible harm.

Traumatic cataract can appear within days of blunt or penetrating injury, often with a rosette or stellate shape, and it may combine with lens dislocation.

Radiation cataract, from therapeutic head and neck radiation, typically appears as posterior subcapsular opacity, is dose dependent, and can emerge several years after exposure with a threshold near 0.5 to 2 Gray.

Diabetic cataract has two forms: a slow senile type resembling cortical or PSC cataract, and a rare true diabetic cataract with rapid snowflake opacities in young patients with poor glycemic control.

Misconceptions Worth Correcting

The biggest misconception is that cataract cannot be prevented. While you cannot reverse one, risk reduction is real. UV-blocking sunglasses reduce cortical cataract risk meaningfully, and smoking cessation lowers risk over decades.

A second misconception is that cataracts must be "ripe" before surgery. That outdated rule caused needless years of poor vision. Modern practice operates when the cataract limits the patient's quality of life, not at a fixed maturity stage.

A third misconception concerns eye drops. No topical drop, vitamin regimen, or supplement has been shown to reverse cataract, and the AREDS2 formulation reduces progression of macular degeneration, not cataract.

A final correction: cataract surgery does not "wear out." An intraocular lens is permanent, but a small percentage of patients develop posterior capsule opacification months to years later, which is a separate membrane problem treatable with a brief laser procedure called YAG capsulotomy.

What to Actually Do

  • Get a dilated eye exam if you notice new glare, night halos, or color dulling, since the type of cataract changes the timing conversation.
  • Use UV400 sunglasses outdoors, especially at high altitude and near water, to reduce cortical cataract progression.
  • Keep HbA1c below 7 percent if you have diabetes, which mitigates the osmotic pathway driving cortical and PSC cataract.
  • Review all steroid use, inhaled and topical included, with your physician if a PSC pattern appears.
  • Track functional vision, not just chart acuity, such as night driving and reading in bright light.
  • Discuss surgery when daily tasks, driving, or reading decline, rather than waiting for a fixed "ripe" stage.

Red-flag symptoms that warrant prompt evaluation:

  • Sudden vision loss in one eye
  • Flashes of light or a new curtain across vision
  • Painful red eye with vision change
  • Rapid glare worsening over weeks
  • Double vision in one eye
  • Halos that appear abruptly and persist

Limits of What the Evidence Shows

Cataract type classification is well established, but progression prediction is not precise. Two patients with identical nuclear scores can decline at very different rates, and no validated model predicts individual surgical timing precisely.

The protective evidence for antioxidants and dietary factors is mixed, with observational studies suggesting benefit and randomized trials mostly showing none. Treat those claims as hypothesis, not established fact.

What is established: type identification guides counseling, steroid and diabetes linkages are well documented, and surgery restores vision in the overwhelming majority of cases, with modern phacoemulsification carrying a serious complication rate of well under 2 percent in uncomplicated eyes per major ophthalmology society data.